EUVIMEDEUVIMED entdecken
Systematische ÜbersichtMetaanalyseOpen Access · CC BY 4.0

Efficacy and Safety of Pulsed‐Field Versus High‐Power Short‐Duration Ablation for Atrial Fibrillation: A Systematic Review and Meta‐Analysis With Reconstructed Time‐to‐Event Data

Ahmed Mazen Amin iD, Mustafa Turkmani iD, Saman Al Barznji, Sanghamitra Mohanty, Rachel M Kaplan iD, Jeffrey Winterfield, Dhanunjaya Lakkireddy, Pasquale Santangeli iD, Luigi Di Biase iD, Andrea Natale iD

Journal of Cardiovascular Electrophysiology · 2025-08 · 36 (8) · 1762-1784

DOI: 10.1111/jce.16728 ↗

Kurz gefasst

Systematische Übersicht in der Zeitschrift Journal of Cardiovascular Electrophysiology, online erschienen am 28.05.2025. Verfasst von Ahmed Mazen Amin und 9 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Mansoura University, Mansoura, Egypt. Hauptthemen laut MEDLINE: Atrial Fibrillation, Catheter Ablation, Pulmonary Veins. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The authors received no specific funding for this work..

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Pulsed‐field ablation (PFA) and high‐power short‐duration (HPSD) ablation (45–90 W) are emerging technologies in atrial fibrillation (AF) treatment, both achieving durable pulmonary vein isolation. We aim to investigate the efficacy and safety of PFA versus HPSD ablation.

Methods

We comprehensively searched PubMed, Web of Science (WOS), Scopus, EMBASE, and Cochrane Central Register of Controlled Trials (CENTRAL) through July 2024. Pairwise meta‐analysis with reconstructed time‐to‐event analysis were performed using R version 4.3.1 (PROSPERO ID: CRD42024576031).

Results

Seven observational studies, including 1904 patients, were included. PFA was significantly associated with lower atrial tachyarrhythmia recurrence compared to HPSD ablation (45–90 W) at the longest follow‐up (RR: 0.73, 95% CI [0.60, 0.88], p < 0.01). Subgroup analysis revealed a significant reduction in atrial tachyarrhythmia recurrence with PFA versus HPSD ablation (45–50 W) (RR: 0.69, 95% CI [0.54, 0.88], p < 0.01), but not compared to vHPSD ablation (70–90 W). Reconnected pulmonary vein rates were significantly lower with PFA compared to HPSD (45–50 W) ( p = 0.03), while no significant difference was observed compared to vHPSD (70–90 W). PFA was significantly associated with reduced procedural duration (MD: −33.15 with 95% CI [−40.93, −25.36], p < 0.01) and left atrial dwell time (MD: −32.16 with 95% CI [−45.55, −18.77], p < 0.01), although fluoroscopy time increased (MD: 7.48 with 95% CI [4.29, 10.68], p < 0.01) compared to HPSD ablation (45–90 W). Safety profiles were comparable, but pericarditis rates were significantly lower with PFA versus HPSD (45–50 W) ( p = 0.003) and vHPSD (70–90 W) ( p = 0.019). Kaplan–Meier analysis showed a 28% lower risk of atrial tachyarrhythmia recurrence with PFA compared to HPSD ablation (45–90 W) (HR: 0.72, 95% CI [0.57, 0.91], p = 0.006) over an 18‐month follow‐up.

Conclusion

PFA and HPSD ablation (45–90 W) are effective and safe for AF ablation. PFA was significantly associated with lower atrial tachyarrhythmia recurrence, shorter procedural duration, reduced left atrial dwell time, increased fluoroscopy time, and comparable safety, with lower rates of pericarditis compared to HPSD ablation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationCatheter AblationPulmonary VeinsHumansTime FactorsTreatment OutcomeRecurrenceAction PotentialsRisk FactorsHeart RateMaleMiddle AgedFemaleAgedObservational Studies as TopicRisk Assessment

Stichwörter der Autor:innen

atrial fibrillationcatheter ablationhigh‐power short‐durationpulmonary vein isolationpulsed‐field ablation

Autor:innen und Institutionen

  • Faculty of Medicine, Mansoura University, Mansoura, Egypt.
  • Faculty of Medicine, Michigan State University, Faculty of Medicine, East Lansing, Michigan, USA.
  • Department of Internal Medicine, McLaren Health Care, Oakland, Michigan, USA.
  • Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin, Texas, USA.
  • Section of Cardiac Electrophysiology, Division of Cardiology, Medical University of South Carolina (MUSC), Charleston, South Carolina, USA.
  • Kansas City Heart Rhythm Institute, Overland Park, Kansas, USA.

ORCID-Profile: Ahmed Mazen Amin, Mustafa Turkmani, Rachel M Kaplan, Pasquale Santangeli, Luigi Di Biase, Andrea Natale

Förderung

  • The authors received no specific funding for this work.

Zitieren

APA

Amin, A. M., Turkmani, M., Al Barznji, S., Mohanty, S., Kaplan, R. M., Winterfield, J., Lakkireddy, D., Santangeli, P., Di Biase, L., & Natale, A. (2025). Efficacy and Safety of Pulsed‐Field Versus High‐Power Short‐Duration Ablation for Atrial Fibrillation: A Systematic Review and Meta‐Analysis With Reconstructed Time‐to‐Event Data. Journal of Cardiovascular Electrophysiology, 36(8), 1762-1784. https://doi.org/10.1111/jce.16728

Vancouver

Amin AM, Turkmani M, Al Barznji S, Mohanty S, Kaplan RM, Winterfield J, et al. Efficacy and Safety of Pulsed‐Field Versus High‐Power Short‐Duration Ablation for Atrial Fibrillation: A Systematic Review and Meta‐Analysis With Reconstructed Time‐to‐Event Data. Journal of Cardiovascular Electrophysiology. 2025;36(8):1762-1784. doi:10.1111/jce.16728

BibTeX
@article{Amin2025,
  author = {Amin, Ahmed Mazen and Turkmani, Mustafa and Al Barznji, Saman and Mohanty, Sanghamitra and Kaplan, Rachel M and Winterfield, Jeffrey and Lakkireddy, Dhanunjaya and Santangeli, Pasquale and Di Biase, Luigi and Natale, Andrea},
  title = {Efficacy and Safety of Pulsed‐Field Versus High‐Power Short‐Duration Ablation for Atrial Fibrillation: A Systematic Review and Meta‐Analysis With Reconstructed Time‐to‐Event Data},
  journal = {Journal of Cardiovascular Electrophysiology},
  year = {2025},
  volume = {36},
  number = {8},
  pages = {1762--1784},
  doi = {10.1111/jce.16728}
}
Kostenlos starten →